Medindia
Medindia LOGIN REGISTER
Advertisement

Sanmina-SCI Lod, Israel Facility Achieves ISO 13485:2003 Certification for Medical Devices

Tuesday, August 10, 2010 Drug News
Advertisement
SAN JOSE, Calif., Aug. 10 /PRNewswire-FirstCall/ -- Sanmina-SCI Corporation (Nasdaq: SANM), a leading global Electronics Manufacturing Services (EMS) company, today announced that its Lod, Israel, facility has received ISO 13485:2003 certification for the manufacture of prototypes, printed circuit board assemblies (PCBAs), electro-mechanical assemblies, subsystems and systems for electrical medical devices.
Advertisement

ISO 13485 is an internationally recognized standard developed to ensure that companies provide medical devices that consistently meet regulatory requirements. In order to obtain the certification, Sanmina-SCI demonstrated the ability to consistently meet strict requirements for Quality Management Systems (QMS) applicable to medical device manufacturing and related services.
Advertisement

"Earning the ISO 13485:2003 certification represents a significant accomplishment for the Lod, Israel, facility as it emphasizes Sanmina-SCI's commitment to meeting the highest standards of quality required by its medical customers," said Gelston Howell, Senior Vice President of Sanmina-SCI's Medical Division. "Our ability to support medical customers in Lod, Israel, complements Sanmina-SCI's global strategy, and reinforces our growth and leadership position for this key market segment. We have an excellent global network of 14 ISO 13485:2003 certified facilities that include Lod and Ma'alot, Israel. These facilities are also FDA registered and/or QSR compliant ensuring that Sanmina-SCI meets the stringent requirements of the medical industry," concluded Howell.

"Receiving the ISO 13485:2003 certification clearly demonstrates Sanmina-SCI's dedication to offer worldwide manufacturing locations to its medical customers," stated Samuel Semel, Sanmina-SCI's General Manager and Managing Director for Israel. "This key certification opens new opportunities for medical device manufacturing to our customers who are looking for lower-cost and quality solutions in this region."

Sanmina-SCI's Medical Division leverages more than 20 years of experience with a large global network of FDA-registered, ISO 13485:2003 certified medical design and manufacturing facilities. The Medical Division offers medical device Original Equipment Manufacturers (OEMs) complete end-to-end manufacturing services from engineering and manufacturing to logistics and repair/returns management, specializing in a full range of medical devices, from hand-held and medium-sized products, such as ultrasound systems and dermatological lasers, to highly complex equipment that includes Computed Tomography (CT) equipment and complete Nuclear Medicine gantries and tables.

About Sanmina-SCI

Sanmina-SCI Corporation is a leading electronics contract manufacturer serving the fastest-growing segments of the global Electronics Manufacturing Services (EMS) market. Recognized as a technology leader, Sanmina-SCI provides end-to-end manufacturing solutions, delivering superior quality and support to OEMs primarily in the communications, defense and aerospace, industrial and semiconductor systems, medical, multimedia, enterprise computing and storage, automotive technology and renewable energy sectors. Sanmina-SCI has facilities strategically located in key regions throughout the world. More information regarding the company is available at http://www.sanmina-sci.com.

Sanmina-SCI Safe Harbor Statement

The foregoing, including the discussion regarding the Company's future prospects, contains certain forward-looking statements that involve risks and uncertainties, including uncertainties associated with economic conditions in the electronics industry, particularly in the principal industry sectors served by the Company, changes in customer requirements and in the volume of sales principal customers, the ability of Sanmina-SCI to effectively assimilate acquired businesses and achieve the anticipated benefits of its acquisitions, and competition and technological change. The Company's actual results of operations may differ significantly from those contemplated by such forward-looking statements as a result of these and other factors, including factors set forth in our Company's fiscal year 2008 Annual Report on Form 10-K and fiscal 2009 quarterly reports on Form 10-Q filed with the Securities Exchange Commission.

SOURCE Sanmina-SCI Corporation

Sponsored Post and Backlink Submission


Latest Press Release on Drug News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close